Comorbidities in rheumatic and musculoskeletal diseases (RMDs) not only increase
morbidity and mortality but also confound disease activity, limit drug usage and increase …

Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale …

Introduction/objectives The current 2019 novel coronavirus outbreak is continuing to spread
rapidly despite all efforts. Patients with rheumatic disease may have higher levels of anxiety …

Background It is unclear whether chronic use of immunosuppressive drugs worsens or
improves the severity of coronavirus disease 2019 (COVID-19), with plausible mechanisms …

Objective To determine health perceptions of patients with rheumatic diseases in the early
phase of the coronavirus disease 2019 (COVID‐19) pandemic. Methods Rheumatology …

As of June 10th 2020 about 7.2 million individuals have tested positive for, and more than
410,000 have died due to COVID-19. In this review we outline the pathophysiology that …

As it is known, we are all in a pandemic situation due to a novel coronavirus, officially named
“Severe Acute Respiratory Syndrome Coronavirus 2” and the disease caused by the virus …

With great interest, we read the recommendations from the German Society of
Rheumatology regarding the management of patients with rheumatic diseases during the …

Objective To evaluate the safety and utility of core needle biopsy (CNB) for diagnosis of
salivary gland lymphoma in Sjögren's syndrome (SS). Methods We analyzed data from …

Importance: Since the beginning of the Coronavirus Disease-19 (COVID-19) pandemic,
Severe Acute Respiratory Syndrome-CoV-2 (SARS-CoV-2) infection has been a serious …